Solid Biosciences to Showcase Proprietary Next-Generation Capsid AAV-SLB101 and Cardiac Gene Therapy Pipeline at the 22nd Global CardioVascular Clinical Trialists (CVCT) Forum

(NASDAQ:SLDB), CHARLESTOWN, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it will present data from its next-generation, proprietary capsid AAV-SLB101 and its cardiac gene therapy pipeline at the Global CardioVascular Clinical […]

Osisko Development Launches Fully-Funded 70,000-Meter Exploration Drilling Campaign Targeting New Discoveries at Cariboo Gold Project

(TSX-V:ODV),(NYSE:ODV), HIGHLIGHTS1 Fully-funded 70,000-meter exploration drill program launched with two drill rigs already operating at the Cariboo Gold Project site, and ramping up to six drill rigs as the program advances through the end of 2026 Priority exploration targets and initial planned drilling: Cariboo Deep (~10,000 m, 11 holes) – targeting areas at depth beneath

Soleo Health Appoints Jody Thompson as New Senior Vice President of Business Development, Rare Disease

FRISCO, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the appointment of Jody Thompson to the role of senior vice president of business development, rare disease. Thompson will augment the strategy to broaden Soleo Health's portfolio of exclusive and limited distribution

SPX Technologies to Acquire Crawford United

(NYSE:SPXC), CHARLOTTE, N.C. and CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE:SPXC) (“SPX” or the “Company”) and Crawford United Corporation (OTC: CRAWA) (“Crawford United”) announced today that they have entered into a definitive agreement for SPX to acquire Crawford United, a Cleveland-based holding company with a broad portfolio of highly engineered air

Refined Energy Corp. Receives Formal Drill Program Proposal for Dufferin Project Drill Program

(CNSX:RUU.CN),(CNSX:RUU),(Boerse Frankfurt – Freiverkehr:CWA0),(Boerse Frankfurt – Freiverkehr:CWA0.F),(OTC US:RRUUF),(Other OTC:RRUUF), VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — Refined Energy Corp. (CSE: RUU; OTC: RRUUF; FRA: CWA0) (“Refined” or the “Company“) is pleased to announce that it has received a formal drill program proposal from Eagle Plains Resources Ltd. (“Eagle Plains”). The program is driven

AmpliTech Achieves Major Milestone in 5G Innovation: First and only U.S. Company to Validate High-Capacity 64T64R CAT-B Massive MIMO Radios in Global Open RAN Testing with G-REIGN (HTC) And Digital Catapult SONIC Labs

(NASDAQ:AMPG),(NASDAQ:AMPGW), HAUPPAUGE, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (NASDAQ: AMPG) (“AmpliTech” or the “Company”) today announced a breakthrough achievement in the 5G telecommunications market. The Company successfully completed the initial phase of rigorous testing of its advanced 64T64R CAT-B Massive MIMO O-RU during the O-RAN Global PlugFest Fall 2025. This achievement

BIO-key Answers the Call for Secure, Modern Authentication with New Passwordless Innovations at the 2025 Gartner(R) IAM Summit: North America

(NASDAQ:BKYI), GRAPEVINE, Texas & HOLMDEL, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) — BIO-key(R) International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions enabling phoneless, tokenless, passwordless, and phishing-resistant authentication, today announced its participation in the 2025 Gartner(R) Identity & Access Management Summit: North America, December 8-10 in

Ascent Solar Technologies Announces Up To $5.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

(NASDAQ:ASTI), THORNTON, Colo., Dec. 08, 2025 (GLOBE NEWSWIRE) — Ascent Solar Technologies, Inc. (NASDAQ: ASTI) (“Ascent” or the “Company”), today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 1,025,643 shares of common stock (or pre-funded warrants in lieu thereof), series A warrants to purchase up

ASUS Announces Always Incredible Virtual Launch Event for CES 2026

(TAI:2357.TW), KEY POINTS Next-Level AI PCs: ASUS to unveil a new generation of adaptive, AI-driven devices with powerful NPUs that deliver intelligent, seamless experiences Comprehensive Ecosystem: ASUS to spotlight three key AI scenarios, Workspace AI, Creator AI, and Everyday AI Inspiring Innovation: ASUS is deeply integrating AI into everyday life, delivering intelligent computing solutions that

Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenstrom Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

(NasdaqGM:NRIX), Objective response rate (ORR) of 75.0% including three very good partial responses (VGPR) in heavily pre-treated Waldenstrom macroglobulinemia patients With a median follow up of 8.1 months, median duration of response (DOR) and median progression-free survival (PFS) have not been reached Encouraging efficacy and favorable tolerability support continued development of bexobrutideg in Waldenstrom macroglobulinemia

Scroll to Top